K.M.P. Biotech Co., Ltd., in collaboration with UNOVETGROUP, hosted “MICROBIOME Seminar 2026: Unlocking New Possibilities in Companion Animal Health,” bringing together scientific knowledge, research insights, and clinical perspectives on the microbiome and probiotics to advance companion animal health.
Held on 5 August 2026 at the Grand Chambray Ballroom, 7th Floor, Avani Sukhumvit Bangkok, the seminar was organized under the theme:
The event aimed to deepen understanding of the role of the microbiome in companion animal health while creating a platform for the exchange of scientific knowledge, research findings, and clinical perspectives. By connecting fundamental microbiome science with veterinary practice, the seminar highlighted the potential of evidence-based approaches to support the health and well-being of dogs and cats.
Throughout the seminar, participants gained insights from distinguished academics, researchers, and veterinary professionals on key topics related to microbiome science and companion animal health, including:
– Functional Microorganisms and their journey from scientific discovery to practical application
– Oral Microbiome & Probiotics and their relevance to canine oral health
– The clinical significance and future perspectives of the GI Microbiome in companion animals
– Diagnosis, treatment, and long-term management of Chronic Enteropathy in Dogs and Cats
– Hyperlipidemia and Liver Disease in companion animals, including perspectives on the role of the gut microbiome
A key focus of the seminar was the integration of knowledge across multiple disciplines, enabling participants to view the microbiome not only from a research perspective but also in the context of its potential application in veterinary clinical practice.
The seminar was honored to welcome distinguished academics, researchers, and veterinary experts from leading universities and research institutions in Thailand.
Their presentations covered a broad spectrum of topics, ranging from functional microorganisms and probiotic research to gastrointestinal health, chronic enteropathy, metabolic conditions, liver disease, and oral health in companion animals.
The program also featured research on the efficacy of SD Lactobacillus probiotic tablets in improving canine oral health, emphasizing the importance of scientific evaluation and evidence-based approaches when exploring the potential applications of probiotics in animal health.
Together, these sessions reflected the seminar’s core concept: transforming scientific knowledge into meaningful perspectives that can support future developments in veterinary medicine.
At K.M.P. Biotech, our commitment to microbiome and probiotic science extends beyond product development. We place strong emphasis on research, scientific collaboration, knowledge development, and the exchange of evidence-based information among researchers, veterinarians, and professionals across the animal health sector.
MICROBIOME Seminar 2026 represents another step in this commitment, providing a platform that connects scientific discovery with clinical perspectives under the concept of “From Science to Clinical Practice.”
Through continued collaboration with academic institutions, researchers, veterinarians, and industry partners, K.M.P. Biotech aims to contribute to the advancement of microbiome knowledge and its responsible application in companion animal health.
K.M.P. Biotech Co., Ltd. would like to extend our sincere appreciation to all distinguished speakers, special guests, veterinarians, and participants for contributing to the success of this seminar.
We would also like to thank UNOVETGROUP for its valued collaboration in creating a meaningful platform for scientific learning and professional exchange.
We believe that meaningful innovation in animal health begins with science, is strengthened by research, and creates value through responsible application.
Stay connected with K.M.P. Biotech for future seminars, research updates, and scientific insights on microbiome and probiotic applications in animal health.